MAUDE Adverse Event Report: COOK INC BLUE RHINO G2-MULTI PERCUTANEOUS TRACHEOSTOMY INTRODUCER TRAY; JOH TUBE TRACHEOSTOMY AND TUBE CUFF

Model Number	N/A
Medical Device Problem Codes	Difficult to Insert (1316); Device-Device Incompatibility (2919)
Health Effect - Clinical Code	Upper Respiratory Tract Injury (4599)
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Blank fields on this form indicate the information is unknown or unavailable.E3 - occupation: rrt.G4 ¿ pma/510(k) #: k193133.This report includes information known at this time.A follow-up report will be submitted should additional, relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned or that a death or serious injury occurred; nor is it admission that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
Event or Problem Description
It was reported that the white guiding catheter/blue rhino dilator assembly from a blue rhino g2-multi percutaneous tracheostomy introducer tray malfunctioned.Three different physicians reported that the white guiding catheter/blue rhino dilator assembly was not functioning properly.As result, three patients experienced posterior tracheal wall injury.Additional information regarding the event and patient outcome has been requested but is currently unavailable.This report will capture the patient with identifier: (b)(6).The other two patients will be captured in reports with patient identifiers (b)(6) and (b)(6).
Event or Problem Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
Additional Manufacturer Narrative
This report includes information known at this time.A follow-up report will be submitted should additional, relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned or that a death or serious injury occurred; nor is it admission that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
Event or Problem Description
Additional information was received 26apr2023 regarding the three events.This report will focus on an event reported by one of the physicians.Three possible dates for this event include, (b)(6) 2022, (b)(6) 2023, and (b)(6) 2023.Date clarification has been requested.The physician reported that during a percutaneous tracheostomy procedure, dissection was performed down to just above the trachea, the needle was inserted, and the procedure progressed normally.After the wire and loading dilator were removed from the tracheostomy tube, the tracheostomy tube was connected to the ventilator.No tidal volumes were observed.Bronchoscopy was quickly performed through the tracheostomy tube; however, only tissue was visible, so the tracheostomy tube was retracted by about centimeter.At this time, the anterior pathway into the trachea was visible as well as a posterior pathway into the tissue behind the trachea.The tip of the tracheostomy tube was then angled anteriorly in the tracheal pathway to achieve ventilation.Assistance from an ear, nose, and throat (ent) physician was requested while the attending physician held the tracheostomy tube in the angled anterior position.After arrival of the ent physician, bronchoscopy was performed.The posterior tracheal tissues were laid flat via visualization from the scope.The tracheostomy tube was repositioned distal to the injury, and the airway was secured.It was noted that the tracheostomy tube remained in place longer prior to downsizing due to this occurrence.As reported, "the patient ended up doing well with no currently identified long term issues.".
Additional Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned or that a death or serious injury occurred; nor is it admission that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
Additional Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned or that a death or serious injury occurred; nor is it admission that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
Event or Problem Description
In a previous follow up report, three possible dates were given for this occurrence.Additional information was received 20jul2023 clarifying that those dates were for another physician.The date of this event remains unknown.
Additional Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Correction: h6 - annex a.Investigation ¿ evaluation.It was reported by a representative of university of new mexico hospital that the blue rhino dilator in a blue rhino g2-multi percutaneous tracheostomy introducer tray (rpn: c-ptisy-100-hc-g-na; lot#: unknown) advanced over the safety ridge of the white guiding catheter.The physician reported that during a percutaneous tracheostomy procedure, dissection was performed down to just above the trachea, the needle was inserted, and the procedure progressed normally.After the wire and loading dilator were removed from the tracheostomy tube, the tracheostomy tube was connected to the ventilator.No tidal volumes were observed.Bronchoscopy was quickly performed through the tracheostomy tube; however, only tissue was visible, so the tracheostomy tube was retracted by about centimeter.At this time, the anterior pathway into the trachea was visible as well as a posterior pathway into the tissue behind the trachea (the tracheal injury).The tip of the tracheostomy tube was then angled anteriorly in the tracheal pathway to achieve ventilation.Assistance from an ear, nose, and throat (ent) physician was requested while the attending physician held the tracheostomy tube in the angled anterior position.After arrival of the ent physician, bronchoscopy was performed.The posterior tracheal tissues were laid flat via visualization from the scope.The tracheostomy tube was repositioned distal to the injury, and the airway was secured.It was noted that the tracheostomy tube remained in place longer prior to downsizing due to this occurrence.As reported, "the patient ended up doing well with no currently identified long term issues." reviews of the complaint history, quality control procedures, manufacturing instructions (mi), and instructions for use (ifu) were conducted during the investigation.The complaint device was not returned.However, the customer did return many devices from different lots.Twenty-one of the returned devices were tested and the safety ridge and blue rhino were within specification.Due to this complaint device not being returned, cook cannot confirm the device was manufactured out of specification.Additionally, a document-based investigation evaluation was performed.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.A review of the device history record (dhr) was unable to be completed due to a lack of lot information.An expanded sales search to the customer was unable to identify the complaint lot.Based on the available information, cook has concluded that the device was manufactured to specification and that there is no evidence suggesting nonconforming product exists either in house or in field.Cook also reviewed product labeling.The lot number was not provided; therefore, the most recent ifu packaged with the device was reviewed.The ifu contains the following in relation to the reported failure mode: ¿contraindications¿ ¿ patients with enlarged thyroids.¿ nonpalpable cricoid cartilage.¿ previous surgery at the tracheostomy site (e.G.Thyroidectomy).Potnetial adverse events: ¿ perforation of the trachea.¿ failed tracheostomy tube placement.¿ hypoxia.Tracheostomy procedure: 1.Palpate the landmark structures (thyroid notch, cricoid cartilage) to ascertain proper location for tracheostomy tube placement.Access and ultimately tube placement is ideally made at the level between the first and second tracheal cartilages or between the second d third tracheal cartilages whenever feasible.2.¿ make a 1.5-2.0 cm skin incision (vertical or horizontal) at the chosen insertion site ¿ note: an adequate skin incision and blunt dissection of the subcutaneous tissue can minimize the need for excessive force¿ 13.Activate the hydrophilic coating by immersing the distal end of the blue rhino g2-multi dilator in sterile water or saline.14.Advance the blue rhino g2-multi dilator and the guiding catheter as a unit over the wire guide, while maintaining wire guide position.Note: align the proximal end of the guiding catheter at the mark on the proximal portion of the wire guide.This will ensure that the distal end of the guiding catheter is properly positioned back on the wire guide, preventing possible trauma to the posterior tracheal wall during subsequent manipulations.Note: bronchoscopic guidance may also prevent possible trauma to the posterior tracheal wall.15.Begin to dilate the tracheal access site by advancing the guiding catheter and blue rhino g2-multi dilator into the trachea.To properly align the dilator on the wire guide/guiding catheter assembly, position the proximal end of the dilator at the single positioning mark on the guiding catheter.This will ensure that the distal tip of the dilator is properly positioned at the safety ridge on the guiding catheter to prevent possible trauma to the posterior tracheal wall during introduction.16.Advance and pull back the dilating assembly several times to effectively dilate the tracheal access site.Note: the wire guide must always lead the dilatory and the guiding catheter assembly to prevent possible trauma to the posterior tracheal wall during dilation.Care should be taken to keep the guiding catheter assembly properly aligned with the mark on the proximal portion of the wire guide.This will ensure that the tip of the guiding catheter assembly does not advance beyond the distal tip of the wire guide within the trachea¿¿ based on the available information, no product returned, and the results of the investigation, cook has concluded that component failure unrelated to manufacturing or design deficiencies contributed to the event.It is possible the patient had torturous anatomy and caused the need for excessive force.Excessive force could have caused the blue rhino to advance over the catheter¿s bump.It¿s also possible the rhino or the guiding catheter was damaged.However, none of these possibilities can be confirmed without additional information and/or physical examination of the complaint device.The appropriate personnel have been notified.Cook will continue to monitor for similar complaints.Per the risk assessment no further action is required.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned or that a death or serious injury occurred; nor is it admission that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
Event or Problem Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.

• Brand Name: BLUE RHINO G2-MULTI PERCUTANEOUS TRACHEOSTOMY INTRODUCER TRAY
• Common Device Name: JOH TUBE TRACHEOSTOMY AND TUBE CUFF
• Manufacturer (Section D): COOK INC; 750 daniels way; bloomington IN 47404
• Manufacturer (Section G): COOK INC; 750 daniels way; bloomington IN 47404
• Manufacturer Contact: jason crouch ; 750 daniels way; bloomington, IN 47404 ; 8123392235
• MDR Report Key: 16797354
• Report Number: 1820334-2023-00497
• Device Sequence Number: 3140332
• Product Code: JOH
• UDI-Device Identifier: 00827002577039
• UDI-Public: (01)00827002577039(17)240401(10)15221134
• Combination Product (Y/N): Y
• Initial Reporter State: NM
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Health Professional,User Facility,Company Representative
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup,Followup,Followup,Followup
• Report Date (Section B): 10/16/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 04/01/2024
• Device Model Number: N/A
• Device Catalogue Number: C-PTISY-100-HC-G-NA
• Device Lot Number: UNKNOWN
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Type of Report(Section G): Fifteen-Day
• Initial Date Received by Manufacturer: 04/14/2023
• Supplement Date Received by Manufacturer: 04/26/2023; 05/26/2023; 07/20/2023; 09/19/2023
• Initial Report FDA Received Date: 04/24/2023
• Supplement Report FDA Received Date: 05/23/2023; 05/31/2023; 08/02/2023; 10/16/2023
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 02/13/2023
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention; Life Threatening
• Patient Sex: Unknown